Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.

Article  PubMed  Google Scholar 

Chen ST, Zhang N, Jiang LR, Gao F, Shao JL, Wang T, Zhang EC, Yu H, Wang X, Zheng JH. Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma. Int J Cancer. 2021;148(3):780–90.

Article  CAS  PubMed  Google Scholar 

Chen S, Jiang L, Gao F, Zhang E, Wang T, Zhang N, Wang X, Zheng J. Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma. Br J Cancer. 2022;126(5):771–7.

Article  CAS  PubMed  Google Scholar 

Gu J, He Z, Huang Y, Luan T, Chen Z, Wang J, Ding M. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma. Dis Markers 2022, 2022:5204831.

Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of Tumours of the urinary system and male genital organs-Part A: renal, Penile, and testicular tumours. Eur Urol. 2016;70(1):93–105.

Article  PubMed  Google Scholar 

Chen S, Zhang E, Jiang L, Wang T, Guo T, Gao F, Zhang N, Wang X, Zheng J. Robust prediction of prognosis and immunotherapeutic response for Clear Cell Renal Cell Carcinoma through Deep Learning Algorithm. Front Immunol. 2022;13:798471.

Article  PubMed  PubMed Central  Google Scholar 

Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.

Article  PubMed  PubMed Central  Google Scholar 

Xing XL, Liu Y, Liu J, Zhou H, Zhang H, Zuo Q, Bu P, Duan T, Zhou Y, Xiao Z. Comprehensive analysis of ferroptosis- and Immune-Related signatures to improve the prognosis and diagnosis of kidney renal clear cell carcinoma. Front Immunol. 2022;13:851312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang G, Guan H, Du Z, Yuan W. Comprehensive Analysis of the butyrate-metabolism-related gene signature in Tumor Microenvironment-infiltrating Immune cells in Clear Cell Renal Cell Carcinoma. Front Cell Dev Biol. 2022;10:816024.

Article  PubMed  PubMed Central  Google Scholar 

Courtney KD, Infante JR, Lam ET, Figlin RA, Rini BI, Brugarolas J, Zojwalla NJ, Lowe AM, Wang K, Wallace EM, et al. Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible Factor-2alpha antagonist in patients with previously treated Advanced Clear Cell Renal Cell Carcinoma. J Clin Oncol. 2018;36(9):867–74.

Article  CAS  PubMed  Google Scholar 

Chao X, Wang P, Ma X, Li Z, Xia Y, Guo Y, Ge L, Tian L, Zheng H, Du Y, et al. Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma. Mol Ther Oncolytics. 2021;22:209–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaldany A, Leopold ZR, Kim JE, Patel HV, Srivastava A, Tabakin AL, Singer EA. Dissecting the role of lymphadenectomy in the management of renal cell carcinoma: past, present, and future. Kidney Cancer J. 2020;18(4):103–8.

PubMed  PubMed Central  Google Scholar 

Kuusk T, Klatte T, Zondervan P, Lagerveld B, Graafland N, Hendricksen K, Capitanio U, Minervini A, Stewart GD, Ljungberg B, et al. Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy. World J Urol. 2021;39(9):3377–83.

Article  PubMed  Google Scholar 

Niikura H, Okamoto S, Yoshinaga K, Nagase S, Takano T, Ito K, Yaegashi N. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol Oncol. 2007;105(3):683–6.

Article  PubMed  Google Scholar 

Wessels F, Schmitt M, Krieghoff-Henning E, Jutzi T, Worst TS, Waldbillig F, Neuberger M, Maron RC, Steeg M, Gaiser T, et al. Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer. BJU Int. 2021;128(3):352–60.

Article  CAS  PubMed  Google Scholar 

Brockmoeller S, Echle A, Ghaffari Laleh N, Eiholm S, Malmstrom ML, Plato Kuhlmann T, Levic K, Grabsch HI, West NP, Saldanha OL, et al. Deep learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancer. J Pathol. 2022;256(3):269–81.

Article  CAS  PubMed  Google Scholar 

Wang X, Chen Y, Gao Y, Zhang H, Guan Z, Dong Z, Zheng Y, Jiang J, Yang H, Wang L, et al. Predicting gastric cancer outcome from resected lymph node histopathology images using deep learning. Nat Commun. 2021;12(1):1637.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, Moore S, Phillips S, Maffitt D, Pringle M, et al. The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013;26(6):1045–57.

Article  PubMed  PubMed Central  Google Scholar 

Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, da Veiga Leprevost F, Reva B, Lih TM, Chang HY, et al. Integr Proteogenomic Charact Clear Cell Ren Cell Carcinoma Cell. 2019;179(4):964–e983931.

CAS  Google Scholar 

Lu MY, Williamson DFK, Chen TY, Chen RJ, Barbieri M, Mahmood F. Data-efficient and weakly supervised computational pathology on whole-slide images. Nat Biomed Eng. 2021;5(6):555–70.

Article  PubMed  PubMed Central  Google Scholar 

He K, Zhang X, Ren S, Sun J. Deep Residual Learning for Image Recognition. In: 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR): 2016; 2016.

Russakovsky O, Deng J, Su H, Krause J, Satheesh S, Ma S, Huang Z, Karpathy A, Khosla A, Bernstein M. ImageNet large scale visual recognition challenge. Int J Comput Vision 2014:1–42.

Lu MY, Chen TY, Williamson DFK, Zhao M, Shady M, Lipkova J, Mahmood F. AI-based pathology predicts origins for cancers of unknown primary. Nature. 2021;594(7861):106–10.

Article  CAS  PubMed  Google Scholar 

Ilse M, Tomczak JM, Welling M. Attention-based Deep Multiple Instance Learning. 2018.

Sun X, Xu W. Fast implementation of DeLong’s Algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Process Lett. 2014;21(11):1389–93.

Article  Google Scholar 

Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–24.

Article  PubMed  Google Scholar 

Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 2002;8(8):816–24.

Article  CAS  PubMed  Google Scholar 

Jiang LR, Zhang N, Chen ST, He J, Liu YH, Han YQ, Shi XQ, Yang JJ, Mu DY, Fu GH, et al. PD-1-Positive Tumor-Associated macrophages define poor clinical outcomes in patients with muscle invasive bladder Cancer through potential CD68/PD-1 complex interactions. Front Oncol. 2021;11:679928.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Cao K, Jin S, Zhu X, Ding J, Peng W. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis. Eur Radiol. 2020;30(10):5738–47.

Article  PubMed  Google Scholar 

Chen S, Jiang L, Zheng X, Shao J, Wang T, Zhang E, Gao F, Wang X, Zheng J. Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer. Cancer Sci. 2021;112(7):2905–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim K, Zhou Q, Christie A, Stevens C, Ma Y, Onabolu O, Chintalapati S, McKenzie T, Tcheuyap VT, Woolford L, et al. Determinants of renal cell carcinoma invasion and metastatic competence. Nat Commun. 2021;12(1):5760.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi X, Xiao Q, Zeng F, Yin H, Li Z, Qian C, Wang C, Lei G, Xu Q, Li C, et al. Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma. Front Oncol. 2020;10:570396.

Article  PubMed  Google Scholar 

Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch H, Grignon DJ, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37(10):1490–504.

Article  PubMed